Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the majority of new drug applications.
Related Posts
China’s bond yields are rising — but economists say deflation worries could soon pull them lower
Chinese commercial banks across the country have rushed to dole out cheaper consumption loans, heeding Beijing’s call to bolster spending.
Goldman Sachs offers its newest option for downside protection in volatile markets
Goldman Sachs Asset Management launched its newest buffer exchange-traded fund this month.
Trump meme coin insiders have to wait additional 90 days before they can sell
President Donald Trump’s meme coin was supposed to unlock for some insider sales, but that move got delayed by 90 days.